Analysis Moderna’s October Script Has Two Storylines, and Only One of Them Is Clinical
Moderna shares climbed 6.1% yesterday, a move that landed alongside a broader rotation into healthcare and value names reported by Reuters. That combination raises a question investors should answer before...